2 completed, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Withdrawn 1 |
Follow efaproxiral: new trials by email Literature Review of efaproxiral trials Research Report on efaproxiral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer Efaproxiral, Whole Brain Radiation Therapy (WBRT), Supplemental Oxygen - Breast Cancer, Metastases | Phase 3 | Completed | Spectrum Pharmaceuticals, Inc | 368 | 2004-02-01 | 2013-05-10 |
| Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer carboplatin, cisplatin, efaproxiral - Lung Cancer | Phase 3 | Withdrawn | Spectrum Pharmaceuticals, Inc | 2002-11-01 | 2013-05-10 | |
| Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases efaproxiral, radiation therapy - Metastatic Cancer | Phase 3 | Completed | Spectrum Pharmaceuticals, Inc | 2000-02-01 | 2021-08-23 |
Brain Neoplasms (2) · Neoplasm Metastasis (2) · Adenocarcinoma of Lung (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
Spectrum Pharmaceuticals, Inc (3)
Canada (3) · United States (3) · Belgium (2) · France (2) · Hungary (2) · Italy (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Chile (1) · Croatia (1) · Germany (1) · Greece (1)
Edward G. Shaw, MD (1) · Hak Choy, MD (1) · John Suh, MD (1)